Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Total 13F shares
-
38,236,900
-
Share change
-
+3,386,385
-
Total reported value
-
$120,464,668
-
Put/Call ratio
-
0%
-
Price per share
-
$3.15
-
Number of holders
-
81
-
Value change
-
-$9,936,151
-
Number of buys
-
37
-
Number of sells
-
51
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q4 2018
As of 31 Dec 2018,
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,236,900 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, Vanguard Group Inc, CITADEL ADVISORS LLC, WS MANAGEMENT LLLP, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.